The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.
The Global Epidemiology of Diabetes and Kidney Disease
Open accessAbstract
The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is noteworthy that age has been consistently validated in numerous studies as a pivotal predictor of DKD (5).”
From Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis (2025) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192
Research works printed but not linked: 1
- 2018, 2017 USRDS Annual Data Report: Executive Summary. Chapter 2: Identification and Care of Patients With CKD, Am J Kidney Dis, 71, S31
Cited by
Sorted by citations
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Gerstein, H. C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R. D., Lam, C. S. P., Khurmi, N. S., Heenan, L., Del Prato, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108269 · Cited by 829
Schalkwijk, C., & Stehouwer, C. D. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 649
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 627
Long non-coding RNAs: From disease code to drug role
Chen, Y., Li, Z., Chen, X., & Zhang, S. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.001 · Cited by 515
The cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386
Gupta, S., Dominguez, M., & Golestaneh, L. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.004 · Cited by 373
Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019
Deng, Y., Li, N., Wu, Y., Wang, M., Yang, S., Zheng, Y., Deng, X., Xiang, D., Zhu, Y., Xu, P., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.672350 · Cited by 352
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
Salvatore, T., Galiero, R., Caturano, A., Rinaldi, L., Martino, A. D., Albanese, G., Salvo, J. D., Epifani, R., Marfella, R., Docimo, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073651 · Cited by 279
Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, P., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055459 · Cited by 255
The Epidemiology of Diabetic Kidney Disease
Hoogeveen, E. K. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2030038 · Cited by 279
Update on diagnosis, pathophysiology, and management of diabetic kidney disease
Sugahara, M., Pak, W. L. W., Tanaka, T., Tang, S. C. W., & Nangaku, M. (2021) · Nephrology · doi:10.1111/nep.13860 · Cited by 188
Kownacka, A. E., Vegelyte, D., Joosse, M., Anton, N., Toebes, B. J., Lauko, J., Buzzacchera, I., Lipinska, K., Wilson, D. A., Geelhoed-Duijvestijn, N., et al. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01429 · Cited by 164
Machine Learning Techniques for Chronic Kidney Disease Risk Prediction
Dritsas, E., & Τρίγκα, Μ. (2022) · Big Data and Cognitive Computing · doi:10.3390/bdcc6030098 · Cited by 156
Combination therapy for kidney disease in people with diabetes mellitus
van Raalte, D. H., Bjornstad, P., Cherney, D. Z. I., de Boer, I. H., Fioretto, P., Gordin, D., Persson, F., Rosas, S. E., Rossing, P., Schaub, J. A., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00827-z · Cited by 127
The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
Lim, J., Kwon, S., Jeon, Y., Kim, Y., Kwon, H., Kim, D. K., Lee, H., Kim, Y.-L., Kim, C., Park, S.-H., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004228 · Cited by 131
Liu, X., Hu, X., Yang, H., Gui, L.-M., Cai, Z.-X., Qi, M.-S., & Dai, C. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500744 · Cited by 124
Hypoglycemic Effects of Plant Flavonoids: A Review
Yen, F. S., Qin, C. S., Xuan, S. T. S., Ying, P. J., Le, H. Y., Darmarajan, T., Gunasekaran, B., & Salvamani, S. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2057333 · Cited by 136
Niu, S., Cao, Y., Chen, R., Bedi, M., Sanders, A. P., DUCATMAN, A. M., & Ng, C. A. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11885 · Cited by 122
Li, J., Pandian, V., Davidson, P. M., Song, Y., Chen, N., & Fong, D. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002260 · Cited by 114
Role of ceramides in the pathogenesis of diabetes mellitus and its complications
Mandal, N. A., Grambergs, R. C., Mondal, K., Basu, S. K., Tahia, F., & Dagogo-Jack, S. E. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107734 · Cited by 112
Song, C., Wang, S., Fu, Z., Chi, K., Geng, X., Liu, C., Cai, G., Chen, X., Wu, D., & Hong, Q. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04803-y · Cited by 107
Chen, S., Li, B., Chen, L., & Jiang, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04233-0 · Cited by 110
Amino acid metabolism in kidney health and disease
Knol, M., Wulfmeyer, V. C., Müller, R., & Rinschen, M. M. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00872-8 · Cited by 111
Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K., & von Scholten, B. J. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2045952 · Cited by 115
Politano, S. A., Colbert, G. B., & Hamiduzzaman, N. (2020) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2020.08.002 · Cited by 93
Ou, H., Wei, M., Li, X., & Xia, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02848-9 · Cited by 106
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Tuttle, K. R., Wong, L., St. Peter, W., Roberts, G., Rangaswami, J., Mottl, A., Kliger, A. S., Harris, R. C., Gee, P. O., Fowler, K., et al. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02980322 · Cited by 87
Hu, S., Wang, J., Liu, E., Zhang, X., Xiang, J., Li, W., Wei, P., Zeng, J., Zhang, Y., & Ma, X. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106481 · Cited by 80
Piccoli, G. B., Zakharova, E., Attini, R., Ibarra-Hernández, M., Orozco-Guillén, A., Alrukhaimi, M. N., Liu, Z.-H., Ashuntantang, G., Covella, B., Cabiddu, G., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110415 · Cited by 79
Defo, A. K., Bakula, V., Pisaturo, A., Labos, C., Wing, S. S., & Daskalopoulou, S. S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15331 · Cited by 81
Sánchez-Fructuoso, A. I., Raba, A. B., Banegas‐Deras, E. J., Vigara, L. A., Valero, R., Esteve, A. F., Vega, L. L. C., Gavela, E., González, E., Coronado, P. S., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad007 · Cited by 82
Mosenzon, O., Raz, I., Wiviott, S. D., Schechter, M., Goodrich, E. L., Yanuv, I., Rozenberg, A., Murphy, S. A., Zelniker, T. A., Langkilde, A. M., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0382 · Cited by 75
Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
Su, P.-P., Liu, D., Zhou, S., Chen, H., Wu, X., & Liu, Z. (2022) · Military Medical Research · doi:10.1186/s40779-022-00385-0 · Cited by 69
Huang, P., Mai, Y., Zhao, J. F., Yi, Y., & Wen, Y. (2024) · Inflammation Research · doi:10.1007/s00011-024-01861-0 · Cited by 74
Srivastava, S. P., Goodwin, J. E., Kanasaki, K., & Koya, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15087 · Cited by 64
Effects of the SGLT-2 Inhibitor Canagliflozin on Adenine-Induced Chronic Kidney Disease in Rats
Ali, B. H., Al‐Salam, S., Suleimani, Y. M. A., Za’abi, M. A., Abdelrahman, A. M., Ashique, M., Manoj, P., Adham, S. A., Hartmann, C., Schupp, N., et al. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000003 · Cited by 64
Agudelo‐Botero, M., Valdez-Ortiz, R., Giraldo‐Rodríguez, L., González-Robledo, M. C., Mino‐León, D., Rosales-Herrera, M. F., Cahuana-Hurtado, L., Rojas-Russell, M. E., & Dávila-Cervantes, C. A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035285 · Cited by 61
The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review
Liu, Z., Gong, J., Huang, W., Lu, F., & Dong, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/3796265 · Cited by 80
Oxidative stress as a culprit in diabetic kidney disease
Su, S., Ma, Z., Wu, H., Xu, Z., & Yi, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121661 · Cited by 62
Optical glucose biosensor built-in disposable strips and wearable electronic devices
Reda, A., El‐Safty, S. A., Selim, M. M., & Shenashen, M. A. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113237 · Cited by 61
Rong, Q., Han, B., Li, Y., Yin, H., Li, J., & Hou, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729384 · Cited by 59
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Lubel, J. S., Woods, R. L., Tran, C., Ryan, J. L., Hodge, A. D., Schneider, H. G., McNeil, J. J., et al. (2023) · Liver International · doi:10.1111/liv.15725 · Cited by 61
Potential biomarkers for early detection of diabetic kidney disease
Hussain, S., Habib, A., Hussain, M. S., & Najmi, A. K. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108082 · Cited by 55
de Kort, B. J., Koch, S. E., Wissing, T. B., Krebber, M. M., Bouten, C. V. C., & Smits, A. I. P. M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113960 · Cited by 58
Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.10.003 · Cited by 56
Chewcharat, A., Prasitlumkum, N., Thongprayoon, C., Bathini, T. J., Medaura, J. A., Vallabhajosyula, S., & Cheungpasitporn, W. (2020) · Medical Sciences · doi:10.3390/medsci8040047 · Cited by 52
Treatment of type 2 diabetes patients with heart conditions
Aktaş, G., Tel, B. M. A., Tel, M. R., & Balci, B. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2204941 · Cited by 49
Azhar, M. K., Anwar, S., Hasan, G. M., Shamsi, A., Islam, A., Parvez, S., & Hassan, M. I. (2023) · Nutrients · doi:10.3390/nu15194297 · Cited by 48
Fu, Y., Yang, L., Liu, L., Kong, L. D., Sun, H. J., Sun, Y., Yin, F., Yan, G., & Wang, X. (2024) · Pharmaceuticals · doi:10.3390/ph17121665 · Cited by 48
Zhao, P., Liu, X., Yue, Z., Zhao, Q., Liu, X., Deng, Y., & Wu, J. (2024) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2024.100152 · Cited by 47
Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes
Klimontov, V. V., & Korbut, A. I. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.014 · Cited by 51
Qassab, M. A., Mneimneh, M., Jradi, A., Derbas, B., Dabboussi, D., Baini, J. K., Katrib, N., Chaarani, N., Attieh, P., Kanaan, A., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040285 · Cited by 61
Dong, Y., Luo, X., Liu, Y., Yan, C., Li, H., Lv, J., Li, Y., & Cui, Y. (2022) · Talanta · doi:10.1016/j.talanta.2022.123592 · Cited by 45
Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013
Koye, D. N., Magliano, D. J., Reid, C. M., Pavkov, M. E., Chadban, S. J., McDonald, S. P., Polkinghorne, K. R., White, S., Paul, C. L., & Shaw, J. E. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.10.005 · Cited by 44
Self-citationSalivary FRAP as A Marker of Chronic Kidney Disease Progression in Children
Maciejczyk, M., Szulimowska, J., Taranta‐Janusz, K., Werbel, K., Wasilewska, A. M., & Zalewska, A. (2019) · Antioxidants · doi:10.3390/antiox8090409 · Cited by 43
Diabetes, Albuminuria and the Kidney—Brain Axis
Smera, D. M. A., Jiménez-Baladó, J., Maisterra, O., Pujadas, F., Soler, M. J., & Delgado, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112364 · Cited by 44
Diagnostic challenges of diabetic kidney disease
Duvnjak, L. S., Božičević, S., & Lovrenčić, M. V. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030501 · Cited by 43
Nevola, R., Alfano, M., Pafundi, P. C., Brin, C., Gragnano, F., Calabrò, P., Adinolfi, L. E., Rinaldi, L., Sasso, F. C., & Caturano, A. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2303106 · Cited by 43
Wang, J., Tao, Y., Zhao, F., Liu, T., Shen, X., & Zhou, L. (2023) · Renal Failure · doi:10.1080/0886022x.2022.2121929 · Cited by 40
Preventing and treating kidney disease in patients with type 2 diabetes
Delanaye, P., & Scheen, A. J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1551362 · Cited by 42
Liu, Q., Yan, W., Runqing, L., Bo, E., Liu, J., & Liu, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.899821 · Cited by 40
Liu, Y., Zhang, L., Zhang, S., Liu, J., Li, X., Yang, K., Yang, D., Liu, Y., Sun, L., Liu, F., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00651-4 · Cited by 40
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Thomas, M. C., Neuen, B. L., Twigg, S. M., Cooper, M. E., & Badve, S. V. (2023) · Endocrine Connections · doi:10.1530/ec-23-0005 · Cited by 45
ABCDE to identify and prevent chronic kidney disease: a call to action
Ferro, C. J., Wanner, C., Luyckx, V. A., Stevens, K., Cerqueira, S. A., Darwish, R. A., Fernández‐Fernández, B., Fiel, D., Filev, R., Grieger, M., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf057 · Cited by 44
Artificial intelligence for early detection of diabetes mellitus complications via retinal imaging
Sobhi, N., Sadeghi-Bazargani, Y., Mirzaei, M., Abdollahi, M., Jafarizadeh, A., Pedrammehr, S., Alizadehsani, R., Tan, R.-S., Islam, S. M. S., & Acharya, U. R. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01596-7 · Cited by 39
Chen, X., Sun, L., Li, D., Lai, X., Wen, S., Chen, R., Zhang, Z., Li, Q., & Sun, S. (2022) · Food & Function · doi:10.1039/d1fo03615g · Cited by 40
SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
Qi, W., Hu, C., Zhao, D., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.801303 · Cited by 38
Zhang, K., Long, M., Dong, W., Li, J., Wang, X., Liu, W., Huang, Q., Ping, Y., Zou, H., Song, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020763 · Cited by 38
Kidney disease and stroke: epidemiology and potential mechanisms of susceptibility
Bobot, M., Suissa, L., Hak, J., Burtey, S., Guillet, B. A., & Hache, G. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad029 · Cited by 43
Vitamin A and retinoid signaling in the kidneys
DiKun, K. M., & Gudas, L. J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108481 · Cited by 38
Rezaee, A., Rahmanian, P., Nemati, A., Sohrabifard, F., Karimi, F., Elahinia, A., Ranjbarpazuki, A., Lashkarbolouki, R., Dezfulian, S., Zandieh, M. A., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29871 · Cited by 36
RetractedZhu, K., Zhang, Y., Lu, Q., Geng, T., Li, R., Wan, Z., Zhang, X., Liu, Y., Li, L., Qiu, Z., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21273-z · Cited by 37
Advanced Nanoscale Build‐Up Sensors for Daily Life Monitoring of Diabetics
El‐Safty, S. A., & Shenashen, M. A. (2020) · Advanced Materials Interfaces · doi:10.1002/admi.202000153 · Cited by 35
Li, R., Lin, S., Tu, J., Chen, Y., Cheng, B., Mo, X., & Xie, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04261-w · Cited by 36
Anthocyanins and Type 2 Diabetes: An Update of Human Study and Clinical Trial
Kozłowska, A., & Nitsch-Osuch, A. S. (2024) · Nutrients · doi:10.3390/nu16111674 · Cited by 34
Non-communicable diseases in the world over the past century: a secondary data analysis
Soodejani, M. T. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1436236 · Cited by 33
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
Song, J., Wang, C., Zhao, T., Zhang, Y., Xing, J., Zhao, X., Zhang, Y., & Zhang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520436 · Cited by 36
A Computational Model of Kidney Function in a Patient with Diabetes
Hu, R., & Layton, A. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115819 · Cited by 33
Dietary regulations for microbiota dysbiosis among post-menopausal women with type 2 diabetes
Singh, V., Park, Y.-J., Lee, G., Unno, T., & Shin, J. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2076651 · Cited by 34
Diabetes mortality: trends and multi-country analysis of the Americas from 2000 to 2019
Antini, C., Caixeta, R. D. B., Luciani, S., & Hennis, A. J. M. (2024) · International Journal of Epidemiology · doi:10.1093/ije/dyad182 · Cited by 32
2023 Diabetic Kidney Disease Fact Sheet in Korea
Kim, N. H., Seo, M. H., Jung, J. H., Han, K., Kim, N. H., & Kim, N. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0310 · Cited by 33
Chu, L., Fuller, M. T., Jervis, K., Ciaccia, A., & Abitbol, A. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.07.015 · Cited by 36
Functioning and mechanisms of PTMs in renal diseases
Liu, Z., Yang, J., Du, M., & Xin, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1238706 · Cited by 31
Shao, M., Chen, D., Wang, Q., Guo, F., Wei, F., Zhang, W., Gan, T., Luo, Y., Fan, X., Du, P., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06078-0 · Cited by 35
Tuttle, K. R., Bain, S. C., Bosch‐Traberg, H., Khunti, K., Rasmussen, S., Sokareva, E., & Cherney, D. Z. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.04.028 · Cited by 32
Griffin, T. P., O’Shea, P. M., Smyth, A., Islam, M. N., Wall, D., Ferguson, J. P., O'Sullivan, E., Finucane, F. M., Dinneen, S. F., Dunne, F., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002125 · Cited by 32
Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases
Zhang, L., & Cao, W. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02141-8 · Cited by 31
Reinhart, G. A., Harrison, P. C., Lincoln, K., Chen, H., Sun, P., Hill, J., Qian, H. S., McHugh, M., Clifford, H., Ng, K. J., et al. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001423 · Cited by 32
Arjmand, B., Tayanloo-Beik, A., Heravani, N. F., Alaei, S., Payab, M., Alavi-Moghadam, S., Goodarzi, P., Gholami, M., & Larijani, B. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00396 · Cited by 30
Trends in diabetes-related complications in Singapore, 2013–2020: A registry-based study
Tan, J. K., Salim, N. N. M., Lim, G. H., Chia, S. Y., Thumboo, J., & Bee, Y. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275920 · Cited by 31
Coughlan, M. T., Ziemann, M., Laskowski, A., Woodruff, T. M., & Tan, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-24851-w · Cited by 29
Jayaraman, S., Prasad, M., Natarajan, S. R., Krishnamoorthy, R., Alshuniaber, M. A., Gatasheh, M. K., Veeraraghavan, V. P., Rajagopal, P., & Palanisamy, C. P. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111443 · Cited by 29
Kadomura, S., Takekuma, Y., Sato, Y., Sumi, M., Kawamoto, K., Itoh, T., & Sugawara, M. (2019) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-019-0142-6 · Cited by 29
Chen, D., Wu, J., & Li, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055296 · Cited by 31
Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications
Li, F., Feng, Y., Ren, Q., Fu, P., & Ma, L. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.114907 · Cited by 30
Mitochondrion-driven nephroprotective mechanisms of novel glucose lowering medications
Afşar, B., Hornum, M., Afşar, R. E., Ertuğlu, L. A., Ortíz, A., Covic, A. C., van Raalte, D. H., Cherney, D. Z. I., & Kanbay, M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.02.016 · Cited by 29
Mora‐Gutiérrez, J. M., Fernández‐Seara, M. A., Echeverría‐Chasco, R., & Garcı́a-Fernández, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112461 · Cited by 29
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Hojs, N. V., Bevc, S., Ekart, R., Piko, N., Petreski, T., & Hojs, R. (2021) · Pharmaceuticals · doi:10.3390/ph14060561 · Cited by 28
Metadata
- Authors
- Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Pavkov, Meda E.
- Venue
- Advances in Chronic Kidney Disease
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 25
- Issue
- 2
- Pages
- 121-132
- ISSN
- 1548-5595 (ISSN-L)
- PMC
- PMC11000253
- OpenAlex
- W2790284551
- Cited by
- 686
- References
- 111
- Citations by year
- 2026: 79 · 2025: 111 · 2024: 137 · 2023: 109 · 2022: 101 · 2021: 78 · 2020: 44 · 2019: 19 · 2018: 7
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Advances in Chronic Kidney Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- diabetes mellitus, chronic kidney disease, type 2 diabetes, end-stage renal disease, diabetes prevalence, diabetes incidence, diabetes mortality, cardiovascular disease, low- and middle-income countries, disease awareness
- MeSH terms
- Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Global Health, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
